Tara Semenkovich, MDWashington University General Surgery Resident Tara Semenkovich, MD, presented a paper on June 24 at the Western Thoracic Surgical Association Annual Meeting comparing the effectiveness of upfront esophagectomy vs. induction chemoradiation in clinical stage T2N0 esophageal cancer. The annual meeting was held in Colorado Springs, Colorado.
A baseline model demonstrated comparable expected overall survival for the two strategies:
- 48.3 months for upfront esophagectomy
- 45.9 months for induction chemoradiation followed by surgery
Induction chemoradiation offers a survival benefit when the probability of pathologic upstaging is greater than 48.1%.
The paper has been submitted for publication to the Journal of Thoracic and Cardiovascular Surgery. Washington University thoracic surgeon Varun Puri, MD, served as Semenkovich's mentor.
Semenkovich has been participating in research and training as part of the Cardiothoracic Surgery T32 Training Program for the past two years, and she is currently supported for the third year of her research by funds from The Foundation for Barnes-Jewish Hospital. She is planning to do a critical care fellowship at the completion of this coming year of research activity. There is a mutual hope that she returns to be a part of the Washington University Cardiothoracic Surgery Early Specialization Program when her critical care fellowship is complete.